Displaying drugs 451 - 475 of 2785 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Siponimod | 516.605 C29H35F3N2O3 | A medication used to treat relapsing multiple sclerosis. | Selective Immunosuppressants / Sphingosine-1-phosphate (S1P) receptor modulators | |
Taurocholic acid | 515.703 C26H45NO7S | The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats... | Bile Acids and Salts / Cholagogues and Choleretics / Cholic Acids / Detergents / Gastrointestinal Agents / Steroids | |
Telmisartan | 514.6169 C33H30N4O2 | An ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics | |
Cefpirome | 514.577 C22H22N6O5S2 | An antibiotic indicated in the treatment of a wide variety of infections in the body. | Anti-Bacterial Agents / beta Lactam Antibiotics / Fourth-Generation Cephalosporins | |
Maraviroc | 513.6655 C29H41F2N5O | A CCR5 co-receptor antagonist used with other antiretroviral medications to treat CCR5-tropic HIV-1 infection. | CCR5 Co-receptor Antagonist / CCR5 Receptor Antagonists / Cyclohexanes / HIV Fusion Inhibitors / Triazoles | |
Strontium ranelate | 513.49 C12H6N2O8SSr2 | A medication used for the management of severe osteoporosis in high-risk postmenopausal women and adult men. | Bone Density Conservation Agents / Strontium | |
Thonzonium | 511.818 C32H55N4O | A cationic surfactant used to disperse exudate and cellular debris, as well as enhance the penetration of antimicrobials. | Amines / Ammonium Compounds / Nitrogen Compounds / Onium Compounds / Surface-Active Agents | |
Cefmenoxime | 511.558 C16H17N9O5S3 | Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria. | Anti-Bacterial Agents / Third-Generation Cephalosporins | |
Pinaverium | 511.52 C26H41BrNO4 | A spasmolytic agent used for the symptomatic treatment of irritable bowel syndrome (IBS) and functional disorders of the biliary tract. | Calcium Channel Blockers / Parasympatholytics | |
Ripretinib | 510.367 C24H21BrFN5O2 | A kinase inhibitor used to treat advanced gastrointestinal stromal tumor (GIST). | Kinase Inhibitor | |
Argatroban | 508.64 C23H36N6O5S | A synthetic direct thrombin inhibitor used for the prevention and treatment of thrombosis related to heparin use. | Anticoagulants / Antithrombins | |
Procinonide | 508.559 C27H34F2O7 | Not Annotated | Not Annotated | |
Difluprednate | 508.5515 C27H34F2O7 | A topical corticosteroid used for the symptomatic treatment of inflammation and pain associated with ocular surgery. | Corticosteroids, Potent (Group III) | |
Linzagolix | 508.42 C22H15F3N2O7S | A selective gonadotropin-releasing hormone (GnRH) receptor antagonist used for the symptomatic treatment of uterine fibroids. | Anti-Gonadotropin-Releasing Hormones | |
Lefamulin | 507.73 C28H45NO5S | A pleuromutilin antibacterial used to treat community-acquired bacterial pneumonia (CABP). | Anti-Bacterial Agents | |
Latanoprostene bunod | 507.624 C27H41NO8 | A prostaglandin analog used to reduce ocular hypertension or treat open-angle glaucoma. | Prostaglandins, Synthetic | |
Ixabepilone | 506.7 C27H42N2O5S | A microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines. | Microtubule Inhibitors / Tubulin Modulators | |
Abemaciclib | 506.606 C27H32F2N8 | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors | |
Cefditoren | 506.578 C19H18N6O5S3 | A broad-spectrum third-generation cephalosporin antibiotic typically used to treat bacterial infections of the skin and respiratory tract. | Anti-Bacterial Agents / Third-Generation Cephalosporins | |
Tovorafenib | 506.29 C17H12Cl2F3N7O2S | A type II RAF inhibitor used to treat pediatric low-grade glioma with BRAF gene mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring / Sulfur Compounds | |
Amprenavir | 505.627 C25H35N3O6S | A protease inhibitor used to treat HIV infection. | Anti-HIV Agents / Antibiotics, Antitubercular / HIV Protease Inhibitors / Protease Inhibitors | |
Chlorhexidine | 505.447 C22H30Cl2N10 | An antiseptic used to sterilize for surgeries and in healthcare practice, to reduce pocket depth in periodontitis, and to treat gingivitis. | Anti-Infective Agents, Local / Antiinfectives and Antiseptics for Local Oral Treatment / Biguanides and Amidines / Medicated Dressings With Antiinfectives | |
Dipyridamole | 504.6256 C24H40N8O4 | A phosphodiesterase inhibitor used to prevent postoperative thromboembolic events. | Platelet Aggregation Inhibitors Excl. Heparin | |
Plerixafor | 502.782 C28H54N8 | A CXCR4 antagonist used in combination with granulocyte-colony stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma. | Anti-HIV Agents / Hematopoietic Stem Cell Mobilizer | |
Hexafluronium | 502.745 C36H42N2 | Used as an adjunct with succinylcholine (or suxamethonium chloride) to prolong muscle relaxation and to prevent succinylcholine-induced muscle fasciculations. | Nicotinic Antagonists |
Displaying drugs 451 - 475 of 2785 in total